Mycophenolate Mofetil for Reducing Cardiovascular Risk in Renal Transplant Recipients
Status:
Terminated
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine if adding or increasing the dose of
CellCept while lowering the dose of tacrolimus (Prograf or Advagraf) or cyclosporine
(Neoral), and/or steroids can reduce the likelihood of developing coronary heart disease in
the next 10 years.
The investigators will calculate the change in risk of developing coronary heart disease
using the Framingham score. The Framingham score is a mathematical equation that includes the
following information: Age, Gender, Diabetes status, Smoking status, Lipids, Blood Pressure.
The Framingham score estimates how likely it is that someone will develop coronary heart
disease over the next 10 years.